About the Authors

Jeffrey D. Jenks

jeffrey.jenks@duke.edu (JDJ); hoeniglmartin@gmail.com (MH)

Affiliations Durham County Department of Public Health, Durham, North Carolina, United States of America, Division of Infectious Diseases, Department of Medicine, Duke University, Durham, North Carolina, United States of America

Chioma Inyang Aneke

Affiliations Department of Laboratory Medicine, National Institutes of Health, Bethesda, Maryland, United States of America, Department of Veterinary Pathology and Microbiology, University of Nigeria, Nsukka, Nigeria

Mohanad M. Al-Obaidi

Affiliation Division of Infectious Diseases, Department of Medicine, University of Arizona, Tucson, Arizona, United States of America

Matthias Egger

Affiliation Division of Infectious Diseases, Medical University of Graz, Graz, Austria

Lorena Garcia

Affiliation Department of Public Health Sciences, UC Davis School of Medicine, Davis, California, United States of America

Tommi Gaines

Affiliation Division of Infectious Diseases and Global Public Health, Department of Medicine, School of Medicine, University of California, San Diego, California, United States of America

Martin Hoenigl

jeffrey.jenks@duke.edu (JDJ); hoeniglmartin@gmail.com (MH)

‡ These authors are joint senior authors on this work.

Affiliations Division of Infectious Diseases, Medical University of Graz, Graz, Austria, Division of Infectious Diseases and Global Public Health, Department of Medicine, School of Medicine, University of California, San Diego, California, United States of America

George R. Thompson III

‡ These authors are joint senior authors on this work.

Affiliations University of California Davis Center for Valley Fever, Sacramento, California, United States of America, Department of Internal Medicine, Division of Infectious Diseases, University of California Davis Medical Center, Sacramento, California, United States of America, Department of Medical Microbiology and Immunology, University of California Davis, Davis, California, United States of America

Competing Interests

I have read the journal’s policy and the authors of this manuscript have the following competing interests: J.D.J. received research funding from Astellas, F2G, and Pfizer. M.M.A. received honoraria from Shionogi and La Jolla pharmaceuticals for participating in advisory board meetings. MH has received research funding from Gilead Sciences Europe Ltd, Astellas, Merck Sharp and Dohme, Scynexis, F2G, Euroimmune and Pfizer. G.R.T has received research grants and consultancy fees from Astellas, Amplyx, Cidara, and Mayne. All other authors declare no conflicts of interest.